Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Tempo Intimedia Tbk. (TMPO)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Tempo Intimedia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Tempo Intimedia Tbk. diperdagangkan di Rp151 (kapitalisasi pasar 168,27 M, volume 24 jam 13,5 jt). Perbedaan utamanya: Tempo Intimedia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TMPO | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 168,27 M |
Volume | — | 13,5 jt |
Lot | — | 135 rb |
Perputaran | — | 2,05 M |
Harga Rata-rata | — | 151,71 |
Nilai Transaksi | — | 2,05 M |
Harga Ekuilibrium Indikatif | — | 151 |
Volume Ekuilibrium Indikatif | — | 1,54 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Tempo Intimedia Tbk.
PT Tempo Inti Media Tbk (the Company) was established under its origin name of PT Arsa Raya Perdana on August 27, 1996 , based on deed No.77 of notary Sulaimansjah, SH. The Company’s articles of association has been amended from time to time, the latest of which was drawn up in notarial deed No.49 dated Sept 29, 2000 of Fathiah Helmi, S.H., relating to, among others, the change of company's name, the increase in authorized and issued capital of the Company in connection with the first offering, and stock split.
Selengkapnya di halaman TMPO →
